These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 35682323)

  • 1. Governance of Heritable Human Gene Editing World-Wide and Beyond.
    Xue Y; Shang L
    Int J Environ Res Public Health; 2022 May; 19(11):. PubMed ID: 35682323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Responsible governance of human germline genome editing in China†.
    Peng Y; Lv J; Ding L; Gong X; Zhou Q
    Biol Reprod; 2022 Jul; 107(1):261-268. PubMed ID: 35640230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human genome editing: how to prevent rogue actors.
    Townsend BA
    BMC Med Ethics; 2020 Oct; 21(1):95. PubMed ID: 33023591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Making sense of heritable human genome editing: Scientific and ethical considerations.
    Greenfield A
    Prog Mol Biol Transl Sci; 2021; 182():1-28. PubMed ID: 34175039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ethics and Global Governance of Human Germline Genome Editing: The Problem of Techno-Scientific Colonialist Paternalism.
    Arguedas-Ramírez G
    CRISPR J; 2020 Apr; 3(2):83-88. PubMed ID: 32315224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imperatives of Governance: Human Genome Editing and the Problem of Progress.
    Hurlbut JB
    Perspect Biol Med; 2020; 63(1):177-194. PubMed ID: 32063595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Geneva Statement on Heritable Human Genome Editing: The Need for Course Correction.
    Andorno R; Baylis F; Darnovsky M; Dickenson D; Haker H; Hasson K; Lowthorp L; Annas GJ; Bourgain C; Drabiak K; Graumann S; Grüber K; Kaiser M; King D; Kollek R; MacKellar C; Nie JB; Obasogie OK; Tyebally Fang M; Werner-Felmayer G; Zuscinova J
    Trends Biotechnol; 2020 Apr; 38(4):351-354. PubMed ID: 32014274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human Germ Line and Heritable Genome Editing: The Global Policy Landscape.
    Baylis F; Darnovsky M; Hasson K; Krahn TM
    CRISPR J; 2020 Oct; 3(5):365-377. PubMed ID: 33095042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An imbalanced approach to governance? An analysis of the WHO's position on human genome editing.
    Thaldar D; Shozi B
    Bioethics; 2023 Sep; 37(7):656-661. PubMed ID: 37329575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Democratic Governance of Human Germline Genome Editing.
    Jasanoff S; Hurlbut JB; Saha K
    CRISPR J; 2019 Oct; 2(5):266-271. PubMed ID: 31599682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Playing it Safe? Precaution, Risk, and Responsibility in Human Genome Editing.
    Chan S
    Perspect Biol Med; 2020; 63(1):111-125. PubMed ID: 32063591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticipatory gaps challenge the public governance of heritable human genome editing.
    Rueda J; Segers S; Hopster J; Kudlek K; Liedo B; Marchiori S; Danaher J
    J Med Ethics; 2024 Jul; ():. PubMed ID: 38955479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Future of global regulation of human genome editing: a South African perspective on the WHO Draft Governance Framework on Human Genome Editing.
    Shozi B; Kamwendo T; Kinderlerer J; Thaldar DW; Townsend B; Botes M
    J Med Ethics; 2022 Mar; 48(3):165-168. PubMed ID: 33762299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How Should We Regulate Heritable Human Genome Editing in Australia?
    Nicol D; Rudge C; Paxton R; Niemeyer S
    J Law Med; 2022 Jun; 29(2):322-336. PubMed ID: 35819374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Why Include the Public in Genome Editing Governance Deliberation?
    Blasimme A
    AMA J Ethics; 2019 Dec; 21(12):E1065-1070. PubMed ID: 31876471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Why human germline genome editing is incompatible with equality in an inclusive society.
    MacKellar C
    New Bioeth; 2021 Mar; 27(1):19-29. PubMed ID: 33459206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Global Governance of Human Genome Editing: What Are the Rules?
    Marchant GE
    Annu Rev Genomics Hum Genet; 2021 Aug; 22():385-405. PubMed ID: 33667117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Scientists' Views on Scientific Self-Governance for Human Genome Editing Research.
    Cadigan RJ; Waltz M; Henderson GE; Conley JM; Davis AM; Major R; Juengst ET
    Hum Gene Ther; 2022 Nov; 33(21-22):1157-1163. PubMed ID: 35850532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Societal and Ethical Impacts of Germline Genome Editing: How Can We Secure Human Rights?
    Halpern J; O'Hara SE; Doxzen KW; Witkowsky LB; Owen AL
    CRISPR J; 2019 Oct; 2(5):293-298. PubMed ID: 31599687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intergenerational monitoring in clinical trials of germline gene editing.
    Cwik B
    J Med Ethics; 2020 Mar; 46(3):183-187. PubMed ID: 31473657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.